Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agios Pharmaceuticals

43.24
+0.06000.14%
Post-market: 43.240.00000.00%16:47 EDT
Volume:723.01K
Turnover:31.11M
Market Cap:2.52B
PE:3.89
High:43.72
Open:42.86
Low:42.26
Close:43.18
52wk High:62.58
52wk Low:23.42
Shares:58.31M
Float Shares:51.35M
Volume Ratio:1.17
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.13
EPS(LYR):11.86
ROE:64.05%
ROA:-25.71%
PB:1.84
PE(LYR):3.65

Loading ...

Agios Pharmaceuticals Q3 Swings to Loss, Revenue Rises

MT Newswires Live
·
Oct 30

Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q3 Net Loss of $1.78, vs. FactSet Est of $1.93 Loss

MT Newswires Live
·
Oct 30

Agios Pharmaceuticals posts $12.9 million third quarter PYRUKYND net revenues

Reuters
·
Oct 30

BRIEF-Agios Pharmaceuticals Q3 Product Revenue USD 12.88 Million Vs. IBES Estimate USD 10.5 Million

Reuters
·
Oct 30

Agios Pharmaceuticals Q3 EPS USD -1.78

THOMSON REUTERS
·
Oct 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Oct 30

Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Disposal of Common Shares

Reuters
·
Oct 30

Agios Pharmaceuticals Advances Mitapivat Study for Sickle Cell Disease and Nephropathy

TIPRANKS
·
Oct 28

Agios Pharmaceuticals’ AG-181 Study: A Potential Game-Changer in Drug Development

TIPRANKS
·
Oct 28

BUZZ-U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences

Reuters
·
Oct 18

BUZZ-Agios rise after European drug regulator panel issues positive opinion for blood disorder drug

Reuters
·
Oct 17

Agios Pharmaceuticals Shares Rise 2% After European Drug Regulator Panel Backs Blood Disorder Drug

THOMSON REUTERS
·
Oct 17

Agios Gets CHMP Backing of Pyrukynd in Thalassemia

Dow Jones
·
Oct 17

Agios Pharmaceuticals Inc - Chmp Adopts Positive Opinion for Agios' Pyrukynd

THOMSON REUTERS
·
Oct 17

Bank of America Securities Remains a Buy on Agios Pharma (AGIO)

TIPRANKS
·
Oct 17

Agios Pharmaceuticals Director David Scadden Reports Disposal of Common Shares

Reuters
·
Oct 11

Agios Pharmaceuticals Director David Scadden Reports Sale of Common Shares

Reuters
·
Oct 03

Theodore James Jr., Principal Accounting Officer, Reports Disposal of Agios Pharmaceuticals Common Shares

Reuters
·
Sep 10

Agios Pharmaceuticals Price Target Maintained With a $56.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 05

BUZZ-U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum

Reuters
·
Sep 04